Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Molina Healthcare plunges after surprise Q4 loss
(Sharecast News) - Shares in Molina Healthcare plunged on Friday after the US managed care group reported an unexpected fourth-quarter loss and issued sharply weaker-than-expected guidance for 2026, triggering a sell-off that drove the stock to a near six-year low. Molina posted an adjusted loss of $2.75 per share for the fourth quarter, compared with market expectations for a profit of 34 cents, as medical costs surged across its Medicaid, Medicare Advantage and Affordable Care Act Marketplace businesses.
Revenue rose 8.3% year-on-year to $11.38bn, beating forecasts, but profitability was hit by roughly $2 per share in adverse retroactive premium adjustments linked to its California Medicaid operations.
The group's consolidated medical care ratio deteriorated to 94.6% from 90.2% a year earlier.
Cost pressures were particularly acute in Molina's Marketplace and Medicare Advantage segments, where medical loss ratios climbed well above expectations, reflecting higher utilisation and weaker risk pools.
Management also flagged a steep contraction in Affordable Care Act Marketplace membership, forecasting a fall to about 220,000 members by the end of 2026 from more than 700,000 in late 2025, as the company exits counties, raises premiums and grapples with the expiry of enhanced federal subsidies.
The outlook for 2026 further unsettled investors.
Molina forecast adjusted earnings of at least $5.00 per share on revenue of at least $44.5bn, far below analyst expectations.
The company said guidance incorporates around $2.50 per share of headwinds, including costs associated with a new Florida Medicaid contract and ongoing losses in traditional Medicare Advantage Part D plans, which it intended to exit in 2027.
Chief executive Joseph Zubretsky described 2026 as a potential "trough year" for Medicaid margins as rates lag underlying cost trends.
Analysts reacted cautiously - Bank of America reiterated an underperform rating, citing limited visibility on Medicaid and exchange risk pools, while Jefferies questioned whether Medicaid margins would stabilise as quickly as management expects.
At 1218 ET (1718 GMT), shares in Molina Healthcare were down 27.92% at $127.50.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.